Literature DB >> 1683350

Identification and characterization of three DNA-binding proteins on the promoter of the human MDR1 gene in drug-sensitive and -resistant cells.

M Ogura1, T Takatori, Y Sugimoto, T Tsuruo.   

Abstract

In multidrug-resistant cell lines (K562/ADM), MDR1 was amplified and transcriptionally activated. But the mechanism of MDR1 expression is unknown in K562/ADM cells. A 131 bp DNA fragment upstream from the major cap site of MDR1 contained CAAT-like and GC-box-like motifs and showed promoter activity in a CAT expression assay, resulting in a 3.5-fold enhancement of MDR1 promoter activity in K562/ADM as compared with that in K562 cells. In the CAT assay using deletion mutants we found that sequences containing the CAAT-like motif and the GC-box-like motif were required for MDR1 proximal promoter activity. To understand the details of MDR1 transcription in K562/ADM cells we analyzed the interaction between the proximal promoter and DNA-binding protein(s). We have identified three DNA-binding proteins on the MDR1 promoter from K562/ADM and parental K562 cells. The first binding protein to the MDR1 promoter was NF-R1, which recognized the sequences containing the CAAT-like motif and the GC-box-like motif as revealed by using a gel mobility shift assay. The second protein was NF-R2, which bound to the sequence containing the CAAT-like motif. The third protein, which bound to the sequence containing the GC-box-like motif was designated NF-R3. NF-R2 and NF-R3 in the resistant cells formed different bands in the gel mobility shift assays as compared with those in the sensitive cells, respectively. The observed difference might be related to the transcriptional activation of MDR1 in K562/ADM cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1683350      PMCID: PMC5918252          DOI: 10.1111/j.1349-7006.1991.tb01770.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


chloramphenicol acetyl transferase adriamycin polymerase chain reac‐tion phenylmethylsulfonyl fluoride dithio‐threitol sodium dodecyl sulfate polyacrylamide gel electrophoresis kilobase kilodalton
  39 in total

1.  Homologous recognition of a promoter domain common to the MSV LTR and the HSV tk gene.

Authors:  B J Graves; P F Johnson; S L McKnight
Journal:  Cell       Date:  1986-02-28       Impact factor: 41.582

2.  Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133.

Authors:  G A Gonzalez; M R Montminy
Journal:  Cell       Date:  1989-11-17       Impact factor: 41.582

3.  Decreased expression of the amplified mdr1 gene in revertants of multidrug-resistant human myelogenous leukemia K562 occurs without loss of amplified DNA.

Authors:  Y Sugimoto; I B Roninson; T Tsuruo
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

4.  Purification and biochemical characterization of the promoter-specific transcription factor, Sp1.

Authors:  M R Briggs; J T Kadonaga; S P Bell; R Tjian
Journal:  Science       Date:  1986-10-03       Impact factor: 47.728

5.  Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts.

Authors:  W T Beck; T J Mueller; L R Tanzer
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

6.  A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta.

Authors:  P Rossi; G Karsenty; A B Roberts; N S Roche; M B Sporn; B de Crombrugghe
Journal:  Cell       Date:  1988-02-12       Impact factor: 41.582

7.  Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16.

Authors:  I Sugawara; I Kataoka; Y Morishita; H Hamada; T Tsuruo; S Itoyama; S Mori
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

8.  Yeast HAP1 activator binds to two upstream activation sites of different sequence.

Authors:  K Pfeifer; T Prezant; L Guarente
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

9.  Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification.

Authors:  D W Shen; A Fojo; J E Chin; I B Roninson; N Richert; I Pastan; M M Gottesman
Journal:  Science       Date:  1986-05-02       Impact factor: 47.728

10.  Octamer transcription factors bind to two different sequence motifs of the immunoglobulin heavy chain promoter.

Authors:  I Kemler; E Schreiber; M M Müller; P Matthias; W Schaffner
Journal:  EMBO J       Date:  1989-07       Impact factor: 11.598

View more
  5 in total

1.  Purification and characterization of NF-R1 that regulates the expression of the human multidrug resistance (MDR1) gene.

Authors:  M Ogura; T Takatori; T Tsuruo
Journal:  Nucleic Acids Res       Date:  1992-11-11       Impact factor: 16.971

Review 2.  Cellular models for multiple drug resistance in cancer.

Authors:  M Clynes
Journal:  In Vitro Cell Dev Biol       Date:  1993-03

3.  Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance.

Authors:  Eran E Bram; Michal Stark; Shachar Raz; Yehuda G Assaraf
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

4.  Epigenetic Regulation of Multidrug Resistance Protein 1 and Breast Cancer Resistance Protein Transporters by Histone Deacetylase Inhibition.

Authors:  Dahea You; Jason R Richardson; Lauren M Aleksunes
Journal:  Drug Metab Dispos       Date:  2020-03-19       Impact factor: 3.922

5.  Purification and characterization of NF-R2 that regulates the expression of the human multidrug resistance (MDR1) gene.

Authors:  T Takatori; M Ogura; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  1993-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.